2012 Editorial Board Conflict of Interest

William F. Balistreri, MD, has received research grants from Roche (2004-2010) and Digestive Care, Inc (2010).

Stephen R. Daniels, MD, PhD, serves on the Editorial Board of Childhood Obesity and Congenital Heart Disease; and serves on the Data Safety and Monitoring Boards of Merck/Schering-Plough and QLT, Inc.

Alan H. Jobe, MD, PhD, serves on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine and the American Journal of Physiology; receives research supplies (surfactant) from Chiesi Pharmaceuticals; and receives honorarium for academic/university-associated speaking engagements.

Sarah S. Long, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Thomas R. Welch, MD, receives a grant from Alexion Pharmaceutical; owns stocks in Phizer, Merck, and Abbott Labs.

Robert W. Wilmott, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Monica L. Helton, BA, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Steven H. Abman, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Pasquale J. Accardo, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Hans C. Andersson, MD, FACMG, serves as a consultant for and receives honorarium from Genzyme, Biomarin, and Shire; and received a grant from Biomarin.

Sharon P. Andreoli, MD, serves as a consultant for Genentech, The National Institute of Diabetes and Digestive and Kidney Diseases, and National Institutes of Health.

Paul H. Dworkin, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Paul G. Fisher, MD, serves on the Editorial Board of the Journal of Neuro-Oncology; owns stock in Johnson and Johnson (less than $5000), and receives grants from AARA, Centers for Disease Control and Prevention, and AAMC.

John G. Frohna, MD, MPH, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Samuel S. Gidding, MD, serves on the Editorial Board of Circulation; receives grants from the National Institutes of Health; employee of Nemours Foundation; serves on the Data Safety and Monitoring Board of Losartan (Merck); and serves as principal investigator for a fish oil trial for high triglycerides in adolescents, which is funded by GlaxoSmithKline;

David C. Goodman, MD, serves on the Editorial Board of Health Services Research; employee of Dartmouth-Hitchcock Clinic and US Federal Government; receives grants or contracts from Robert Wood Johnson Foundation, Health Resources and Services Administration, Department of Health and Human Services (Office of the Assistant Secretary of Planning and Evaluation), National Institute on Aging, National Cancer Institute, and Wellpoint Foundation; receives speaking honorarium from Texas Medical Association, Health Action Council (Cincinnati, Ohio), Richard Stockton College of New Jersey, Iowa Health Business Alliance, Alliance for Academic Internal Medicine, Connecticut Children’s Hospital, Mount Sinai Hospital (New York), World Congress, Rutgers University, Baystate Medical Center, Brigham and Women’s Hospital, ESRI, Inc, Illinois Hospital Association, National Hospice Workgroup, National Association of Health Data Organizations, St. Peters University Hospital (New Brunswick, New Jersey), Massachusetts Hospital Association, Cooper Health System (Camden, New Jersey), Organizzato dal Laboratorio Management e Sanità Scuola Superiore Sant'Ana di Pisa, Kentucky Academy of Family Physicians, Southern Illinois University Health Policy Institute, Ohio University College of Osteopathic Medicine, Institute for Clinical Quality and Value, Marwood Group, American Society of Clinical Oncologists, OR Manager, Delta Health Alliance, SUNY Upstate University, Intermountain Healthcare, Canadian Health Services Research Foundation, Massachusetts Health Data Consortium, Vermont Department of Banking, Insurance, Securities, and Health Care Administration; serves as a consultant for HealthDialog and Colorado Foundation for Medical Care; and provides expert testimony for Seyferth Blumenthal and Harris and American Medical Forensic Specialists.

Catherine M. Gordon, MD, MSc, serves as the Co-Director for the Clinical Investigator Training Program at Harvard Medical School with Pfizer and Merck.

Thomas P. Green, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Terrie E. Inder, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Nancy F. Krebs, MD, MS, has a research contract with Abbott Nutrition; and serves as a consultant for Dannon Institute Scientific Council and Nestle Nutrition.

Wayne J. Morgan, MD, serves as a consultant for Novartis, Genentech, and Cystic Fibrosis Foundation; receives grants from NIH-NHLBI, NIH-NIAID, Cystic Fibrosis Foundation; serves as a speaker at the national Phadia meeting and the local Vertex scientific group meeting.

James F. Padbury, MD, performs serine protease inhibitor assays for Prothera Biologics, Inc; and receives shared grants from the National Institutes of Health.

Zora R. Rogers, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Alan D. Rogol, MD, serves on the Scientific Advisory Board for WhiteWave, Inc, and Global Stevia Institute; and serves as a consultant for Insmed, Ipsen, Abbott, Inc, and NovoNordisk.

Lainie Friedman Ross, MD, PhD, serves on the Editorial Board of Journal of Clinical Ethics, Perspectives in Biology and Medicine, and Theoretical Medicine and Bioethics; and receives royalties from the Oxford University Press for two bioethics books.

Janet H. Silverstein, MD, serves on the Editorial Board of Endocrine Today; receives grants from Bristol Meyer Squibb, Sanofi Aventis, and Daiichi Sankyo; reviews grants for Genentech; and supports growth hormone registries for Lilly, Novo Nordisk, Pfizer, and Serono.

Kristin V. Stahl, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Diana E. Stanescu, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Robin H. Steinhorn, MD, serves on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine; and serves on the Scientific Steering Committee for Actelion.

Philip Toltzis, MD, receives grants from the Ohio Department of Health (pending); and has a contract with BASF.

Reginald L. Washington, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Clyde Wright, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Panna Choudhury, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Carlos Cuello-García, MD, received stipends from Cochrane Collaboration and ITESM School of Medicine (employee since 2000) for travel expenses to Cochrane Colloquium in Madrid, Spain (October 2011); and serves as a consultant and provides expert testimony on the generation of clinical practice guidelines for the national Clinical Practice Guidelines program for CENETEC, Secretary of Health, Mexico.

Philip J. Hashkes, MD, receives honorarium from Novartis and Roche, for several lectures (not on the official speaker’s bureau); served as a consultant for UrlPharma (completed in 2010); receives grants from Food and Drug Administration (2007-2012) and Arthritis Foundation (2006-2007); receives contracts and support for clinical research from Novartis (2010-2011), UrlPharma (2010-2011), Regeneron (2006-2007), Roche (2007-2009), and National Institutes of Health (2006-2009);and received drug and placebo from Regeneron for investigator-initiated study (2008-2010).

Ola Didrik Saugstad, MD, PhD, serves on the Editorial Boards for Journal of Perinatology, Journal of Perinatal Medicine, and Neonatology; provides expert testimony 1-2 times a year; preparing to apply to a patent of a new biochemical asphyxia indicator; received grants from Laerdal Research Foundation; and receives funding from Nycomed for lecturing at medical conferences.

Philip M. Sherman, MD, serves on the Editorial Board of Functional Food Reviews (receives honorarium) and Journal of Infectious Diseases; serves on the External Advisory Boards of Alberta IBD Consortium and University of Cincinnati Digestive Health Center (until 2011); serves as a consultant for and receives honorarium from Proctor and Gamble, Abbott Nutrition, and Mead Johnson Nutrition; owns stock in Antibe Therapeutics; and receives grants from Institut Rosell-Lallemand, Inc.